When tumours were stratified according with CD133 expression, median DFS of CD133 low expressor tumors was longer compared to high expressor cases (80.5 ± 36.8 vs 48.0 ± 39.1 months) and this difference was significant (p = 0.001). The gene discussed is PROM1; the disease is neoplasm.